Evidence map›Paper›PMID 28709447›Full record

ArticleActa neuropathologica communications2017

Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-Tooth 2 trigger aggresome formation and neuronal death.

Arnaud Jacquier, Cécile Delorme, Edwige Belotti, Raoul Juntas-Morales, Guilhem Solé, Odile Dubourg, Marianne Giroux, Claude-Alain Maurage, Valérie Castellani, Adriana Rebelo and 5 more

Abstract readCase Reports
In one paragraph

Article in Acta neuropathologica communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Charcot-Marie-Tooth type 2CC misdiagnosed as Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  4. Article
  5. Neurofilaments in health and Charcot-Marie-Tooth disease.Frontiers in cell and developmental biology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Charcot-Marie-Tooth disease type 2CC due toJournal of neurology, neurosurgery, and psychiatry · 2022
    Observational
  10. First case report of Charcot-Marie-Tooth disease type 2CC with a frameshift mutation of NEFH gene in Greece.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  11. A novel missense pathogenic variant in NEFH causing rare Charcot-Marie-Tooth neuropathy type 2CC.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Defects in Axonal Transport in Inherited Neuropathies.Journal of neuromuscular diseases · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Arnaud JacquierInstitut NeuroMyoGène, Université Lyon1 - CNRS UMR 5310 - INSERM U1217, Lyon, France.
Cécile DelormeDépartement de Neurologie, Hôpital Pitié-Salpêtrière, Paris, France.
Edwige BelottiInstitut NeuroMyoGène, Université Lyon1 - CNRS UMR 5310 - INSERM U1217, Lyon, France.
Raoul Juntas-MoralesClinique du motoneurone et pathologies neuromusculaires, CHRU de Montpellier, Montpellier, France.
Guilhem SoléCentre de références des maladies neuromusculaires, CHU de Bordeaux, Bordeaux, France.
Odile DubourgCentre de référence des maladies neuromusculaires, Hôpital Pitié-Salpêtrière, Paris, France.
Marianne GirouxService de Neurologie, CH de Valenciennes, Valenciennes, France.
Claude-Alain MaurageInstitut de pathologie, CHU de Lille, Lille, France.
Valérie CastellaniInstitut NeuroMyoGène, Université Lyon1 - CNRS UMR 5310 - INSERM U1217, Lyon, France.
Adriana RebeloDr John T. MacDonald Foundation Department of Human Genetics, Institute of Human Genomics, University of Miami, Miller School of Medicine, Miami, USA.
Alexander AbramsDr John T. MacDonald Foundation Department of Human Genetics, Institute of Human Genomics, University of Miami, Miller School of Medicine, Miami, USA.
Stephan ZüchnerDr John T. MacDonald Foundation Department of Human Genetics, Institute of Human Genomics, University of Miami, Miller School of Medicine, Miami, USA.
Tanya StojkovicInstitut de Myologie, Hôpital Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013, Paris, France. tanya.stojkovic@aphp.fr.
Laurent SchaefferInstitut NeuroMyoGène, Université Lyon1 - CNRS UMR 5310 - INSERM U1217, Lyon, France. laurent.schaeffer@univ-lyon1.fr.ORCID 0000-0001-6600-503X
Philippe LatourUnité fonctionnelle de neurogénétique moléculaire, CHU de Lyon - HCL groupement Est, Bron, France.

Funding

Uncovering new genes and disease modifiers for ALS and related disordersU54NS092091 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Michael Benatar · 2014 to 2026
$19.8M
trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI ZUCHNER, STEPHAN · 2009 to 2023
$19.6M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
NINDS NIH HHS R01 NS072248NINDS NIH HHS U54 NS065712NINDS NIH HHS U54 NS092091
6 · The paper itself

Abstract

Neurofilament heavy chain (NEFH) gene was recently identified to cause autosomal dominant axonal Charcot-Marie-Tooth disease (CMT2cc). However, the clinical spectrum of this condition and the physio-pathological pathway remain to be delineated. We report 12 patients from two French families with axonal dominantly inherited form of CMT caused by two new mutations in the NEFH gene. A remarkable feature was the early involvement of proximal muscles of the lower limbs associated with pyramidal signs in some patients. Nerve conduction velocity studies indicated a predominantly motor axonal neuropathy. Unique deletions of two nucleotides causing frameshifts near the end of the NEFH coding sequence were identified: in family 1, c.3008_3009del (p.Lys1003Argfs*59), and in family 2 c.3043_3044del (p.Lys1015Glyfs*47). Both frameshifts lead to 40 additional amino acids translation encoding a cryptic amyloidogenic element. Consistently, we show that these mutations cause protein aggregation which are recognised by the autophagic pathway in motoneurons and triggered caspase 3 activation leading to apoptosis in neuroblastoma cells. Using electroporation of chick embryo spinal cord, we confirm that NEFH mutants form aggregates in vivo and trigger apoptosis of spinal cord neurons. Thus, our results provide a physiological explanation for the overlap between CMT and amyotrophic lateral sclerosis (ALS) clinical features in affected patients.

Indexed as

AdultAgedAnimalsApoptosisCell Line, TumorCharcot-Marie-Tooth DiseaseChick EmbryoFamilyFemaleHumansMaleMiceMiddle AgedMutationNeurofilament ProteinsNeuronsneurofilament protein HNeurofilament Proteins

Identifiers

PMID28709447
PMCPMC5513089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.